Pain Physician, 2019 OBJECTIVE To investigate the therapeutic effectiveness of percutaneous kyphoplasty (PKP) combined with zoledronic acid in treatment of primary osteoporotic vertebral compression fractures.
Zi-Feng Huang +3 more
semanticscholar +1 more source
Short-courses of dexamethasone abolish bisphosphonate-induced reductions in bone toughness. [PDF]
, 2013 Bone Biology Laboratory http://www.iupui.edu/~bonelab/ Department of Anatomy and Cell Biology Indiana University School of MedicineAtypical femoral fractures, which display characteristics of brittle material failure, have been associated with potent ...
Allen, Matthew R., Luo, Tianyi D.
core +1 more source
The Oncologist, 2019 Lessons Learned. Adjuvant treatment with zoledronic acid did not decrease the recurrence rate of giant cell tumor of bone (GCTB) in this study. The efficacy could not be determined because of the small sample size. GCTB recurrences, even in the denosumab
A. Lipplaa +6 more
semanticscholar +1 more source
High Serum Concentration of Interleukine-6 and Rank-ligand as Risk Factors for Osteoporosis in Estrogen Deficiency Post-menopausal Women [PDF]
, 2009 Osteoporosis in post-menopausal women is not merely due to deficient estrogenhormone production. The development of osteoporosis is due to increased boneresorption by osteoclasts. The osteoclast\u27s number and activity is controlled by activatingfactors
Bakta, M. (Made) +3 more
core
P4466Inhibition of aortic valve calcification by local delivery of zoledronic acid. An experimental PET/CT study [PDF]
, 2017 Αndreas Synetos +11 more
openalex +1 more source
Bisphosphonates for post-menopausal osteoporosis: are they all the same? [PDF]
, 2017 The primary goal of treatment for post-menopausal osteoporosis (PMO) is reduction in fracture risk. Therefore, clinicians must recommend therapies that are safe and have proven anti-fracture efficacy.
Rizzoli, R.
core
Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study [PDF]
, 2019 Sahar Nasser +3 more
openalex +1 more source
Health Technology Assessment, 2013 Background: Denosumab offers an alternative, or additional, treatment for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumours.
J Ford +10 more
doaj +1 more source
Cardiovascular Safety in Postmenopausal Women and Men With Osteoporosis Treated With Denosumab and Zoledronic Acid: A Post‐Authorization Safety Study [PDF]
, 2023 Leslie Spangler +5 more
openalex +1 more source
Zoledrinic Acid Induces Steoblastic Differentiation of Mesenchymal Stem Cells without Change in Hypomethylation Status of OSTERIX Promoter [PDF]
Cell Journal, 2012 Objective: Mechanism of zoledronic acid on osteoblastic differentiation of mesenchymal stem cells (MSCs) has not fully understood. With the knowledge of some drugs mechanism that alter methylation pattern of some genes, the present research sets out to ...
Maryam Mahmodinia Maymand +5 more
doaj